hyperfine’s mission is to make mri accessible to every patient, regardless of income or resources. anytime. anywhere.hyperfine’s swoop® portable mr imaging system™ addresses limitations of current imaging technologies. swoop wheels directly to a patient’s bedside, where it plugs into a standard electrical outlet and uses an apple ipad® for control. images display within minutes, enabling critical decision-making capabilities across various clinical settings such as neurointensive care units, emergency departments, pediatrics, and more. designed as a complementary system to fixed conventional mri systems, new users can be trained on system operation, device navigation, and safety in about 30 minutes, helping clinicians streamline workflow. the complete swoop™ portable mr imaging system costs less than the annual service contract for most fixed conventional mri systems.in august 2020, swoop received market-ready fda clearance for portable mr imaging of the brain and head for patients of
Company profile
Ticker
HYPR
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
Former names
HealthCor Catalio Acquisition Corp.
SEC CIK
Corporate docs
Subsidiaries
Hyperfine Operations, Inc. • Liminal Sciences, Inc. • Hyperfine Enterprise Ltd ...
HYPR stock data
Latest filings (excl ownership)
S-8
Registration of securities for employees
22 Mar 24
424B5
Prospectus supplement for primary offering
22 Mar 24
10-K
2023 FY
Annual report
22 Mar 24
8-K
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
21 Mar 24
EFFECT
Notice of effectiveness
24 Nov 23
CORRESP
Correspondence with SEC
20 Nov 23
UPLOAD
Letter from SEC
17 Nov 23
8-K
Entry into a Material Definitive Agreement
9 Nov 23
S-3
Shelf registration
9 Nov 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
Transcripts
HYPR
Earnings call transcript
2023 Q4
21 Mar 24
HYPR
Earnings call transcript
2023 Q3
9 Nov 23
HYPR
Earnings call transcript
2023 Q2
14 Aug 23
HYPR
Earnings call transcript
2023 Q1
11 May 23
HYPR
Earnings call transcript
2022 Q4
21 Mar 23
HYPR
Earnings call transcript
2022 Q3
10 Nov 22
HYPR
Earnings call transcript
2022 Q2
11 Aug 22
HYPR
Earnings call transcript
2022 Q1
12 May 22
HYPR
Earnings call transcript
2021 Q4
23 Mar 22
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 85.97 mm | 85.97 mm | 85.97 mm | 85.97 mm | 85.97 mm | 85.97 mm |
Cash burn (monthly) | 2.98 mm | 3.98 mm | 3.92 mm | 4.18 mm | 2.91 mm | 3.93 mm |
Cash used (since last report) | 17.83 mm | 23.81 mm | 23.44 mm | 24.97 mm | 17.38 mm | 23.53 mm |
Cash remaining | 68.14 mm | 62.17 mm | 62.53 mm | 61.00 mm | 68.59 mm | 62.44 mm |
Runway (months of cash) | 22.9 | 15.6 | 16.0 | 14.6 | 23.6 | 15.9 |
Institutional ownership, Q2 2023
33.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 38 |
Opened positions | 5 |
Closed positions | 4 |
Increased positions | 7 |
Reduced positions | 9 |
13F shares | Current |
---|---|
Total value | 18.94 bn |
Total shares | 19.09 mm |
Total puts | 0.00 |
Total calls | 67.50 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Jonathan M Rothberg | 6.87 mm | $5.49 mm |
HC Sponsor | 3.38 mm | $0.00 |
Vanguard | 2.09 mm | $4.49 bn |
FOSUF Fosun International | 1.74 mm | $3.75 bn |
Avidity Partners Management | 1.19 mm | $2.55 bn |
GOOG Alphabet Inc - Ordinary Shares | 898.72 k | $1.93 bn |
BLK Blackrock | 713.70 k | $1.53 bn |
EAM Investors | 541.07 k | $1.16 bn |
Geode Capital Management | 423.73 k | $911.02 mm |
Alyeska Investment | 375.00 k | $806.25 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Feb 24 | Thomas Teisseyre | Class A Common Stock | Sell | Dispose S | No | No | 1.11 | 3,230 | 3.59 k | 96,526 |
16 Nov 23 | Thomas Teisseyre | Class A Common Stock | Sell | Dispose S | No | No | 1.26 | 2,655 | 3.35 k | 99,756 |
16 Aug 23 | Thomas Teisseyre | Class A Common Stock | Sell | Dispose S | No | No | 2.26 | 2,785 | 6.29 k | 102,411 |
16 Aug 23 | Khan Siddiqui | Class A Common Stock | Sell | Dispose S | No | No | 2.26 | 1,729 | 3.91 k | 76,981 |
Press releases
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
21 Mar 24
Hyperfine, Inc. Collaborates with King's College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal
12 Mar 24
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024
7 Mar 24
Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference
28 Feb 24
Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study
1 Feb 24